Multiple myeloma cells show increased CXCL12 production upon interaction with bone marrow stromal cells, thus promoting the recruitment and polarization of M2 TAMs, and subsequently changing the immune status of the tumor towards a more immunoevasive phenotype. The gene discussed is CXCL12; the disease is neoplasm.